-
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. INVAGEN PHARMACEUTICALS, INC., DC CAFC
- 2:15-cv-00281
- D.N.J.
- Judge: Stanley R. Chesler +1
- Filed: 01/14/2015
- Closed: 08/14/2015
- Latest Docket Entry: 02/28/2017
- PACER
- Docket updated daily
2
Plaintiffs
1
Defendant
1
Accused
Product
1
Patent-in-Suit
213
Days in
Litigation
-
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. INVAGEN PHARMACEUTICALS, INC., DC CAFC
- 2:15-cv-00281
- D.N.J.
- Judge: Stanley R. Chesler +1
- Filed: 01/14/2015
- Closed: 08/14/2015
- Latest Docket Entry: 02/28/2017
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
14 |
The imide compound of the formula: ##STR155## or an acid addition salt thereof.
|
Enforceable and Valid
Entry 42 |
-
Infringement
Invagen Pharmaceuticals Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
120mg generic lurasidone20 mg40 mg60 mg80 mg | US 5,532,372 A |
14
|
Infringement
Entry 42
|